The first diagnosis of an Ebola case inside the U.S. added pressure to an already shaky stock market and helped spur a flight to safety in Treasurys.» Read More
CNBC's Simon Hobbs reports on all the market moving events in Europe today, including the latest euro zone manufacturing data and international airlines drop on Ebola fears.
Discussing the company's IPO and competition with Elon Musk's SolarCity, with Greg Butterfield, Vivint Solar CEO.
Strauss Zelnick, Take-Two Interactive chairman & CEO, discusses the upcoming holiday season and the company's plan to stabilize revenue streams.
CNBC's Dominic Chu reports on poor European economic data, and the action at the NYSE surrounding Vivint Solar's IPO.
October could have a long list of market demons to contend with—from the shift in U.S. monetary policy to geopolitical issues that include Hong Kong.
Amazon and Disney are reportedly close to settling a dispute over pricing and promotion. The "Squawk on the Street" news team discusses the dispute and power of Disney.
CNBC's Susan Li reports on the latest developments in Hong Kong. Li says police are keeping a low profile and the composition of the protesters has changed. CNBC's Jim Cramer discusses how the turmoil could impact the U.S. economy.
Discussing global markets after an increase in U.S. private payrolls, CNBC's Jim Cramer says we are in a bifurcated market, stay domestic.
In today's the Good, the Bad and the Ugly, the founder of the world's biggest hedge fund expresses optimism near term, but warns about 2 years down the road. And October gets a bad rap on Wall Street, while Coke responds to critics.
Jim Russell, U.S. Bank Wealth Management, and James Liu, J.P. Morgan Funds, provide perspective on what's driving the market higher and look ahead to fourth quarter expectations.
Shares of Canada's Tekmira Pharmaceuticals soared in premarket trading Wednesday on prospects for its Ebola treatment. So did, Massachusetts-based Sarepta Therapeutics.
Are they hiding in your portfolio? Mad Money host Jim Cramer says get rid of 'em.
Mad Money host Jim Cramer turns to the charts to check out whether the so-called "Death Cross" indicator may be nothing to fear.
Mad Money host Jim Cramer reflects on this year's market trends as the third quarter ends.
Your best plays for October, with Paul Hickey, Bespoke Investment Group.
Patti Domm discusses events that may lead up to market volatility in October.
CNBC's Bertha Coombs discusses the day's activity in the commodities markets. The dollar hit multi-year highs, which hit commodities hard today.
Discussing their market outlook and investment strategies, with retail investors Kamie Zaracki, BetterInvesting CEO, and MBA student Josh Bronstein from the NYU Stern School of Business.
Discussing earnings season and the impact of a strong U.S. dollar, with David Lebovitz, JPMorgan Asset Management; Chris Konstantinos, Riverfront Investment Group; Mark Tepper, Strategic Wealth Partners; and Karyn Cavanaugh, Voya Investment Management.
CNBC's Rick Santelli weighs in on the impact Bill Gross had on Pimco and looks forward to future performance of the institution.